Lakeside Holding Acquires Hupan Pharmaceutical (Hubei) to Enter Medical Logistics in China

Harbin Pharmaceutical Group Acquires GNC Holdings for $1.2 Billion

April 20, 2026

Healthcare Services

Sycamore Partners has sold GNC Holdings, the distressed vitamin retailer it acquired out of bankruptcy in 2021, to China’s Harbin Pharmaceutical Group for $1.2 billion in cash. The deal is expected to close in Q3 2026, subject to regulatory approval, including CFIUS review.

Healthcare Holding Switzerland Acquires Schaublin Medica SA

April 15, 2025

Medical Devices

Healthcare Holding Switzerland AG has acquired 100% of Schaublin Medica SA from its founders as part of a succession plan. Schaublin Medica, based in Plan-les-Ouates, specializes in distribution of vascular grafts, endoprostheses, stents and drug‑coated balloon catheters to hospitals across Switzerland and will join Healthcare Holding's medical-technology platform to expand product and service offerings.

HUTCHMED Divests 45% Stake in Shanghai Hutchison Pharmaceuticals to GP Health Service Capital and Shanghai Pharmaceuticals Holding

January 3, 2025

Pharmaceuticals

HUTCHMED agreed to sell a 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for about US$608 million in cash to GP Health Service Capital Co. and Shanghai Pharmaceuticals Holding. The divestment allows HUTCHMED to reallocate capital to its core oncology and ATTC (antibody-targeted therapy conjugate) pipeline and accelerate its path to profitability.

Huons Acquires 31.5% Stake in PanGen Biotech to Build Biopharma CDMO Capability

November 5, 2024

Biotechnology

Huons Co., Ltd. agreed to acquire 2,647,378 shares and newly issued shares in PanGen Biotech Inc. for KRW 14.3 billion, taking a 31.53% stake and becoming PanGen's largest shareholder with plans to secure management control and incorporate PanGen as a subsidiary. The deal is intended to strengthen Huons' biopharmaceutical R&D and CDMO manufacturing capabilities, including securing GMP production for human-derived hyaluronidase used to enable subcutaneous delivery of biologics.

Linden Capital Partners Acquires LifeStyles Healthcare

December 1, 2022

Consumer Products

Linden Capital Partners has acquired LifeStyles Healthcare, a global sexual health and wellness platform, from a consortium of investors including Trustar Capital and Humanwell Healthcare. The deal excludes LifeStyles' Chinese operations (including the Jissbon brand), which will be retained by the selling shareholders; Linden has named Laurent Faracci as incoming CEO and Ron Fugate as Chairman to drive commercial, brand, and innovation-led growth.

Andlauer Healthcare Group Acquires Logistics Support Unit (LSU) Inc.

March 1, 2022

Logistics & Distribution

Andlauer Healthcare Group Inc. (AHG) has completed its acquisition of 100% of Logistics Support Unit (LSU) Inc. for approximately $30 million, paid via the issuance of 154,639 subordinate voting shares and about $22.5 million in cash. LSU is a Canada-based third-party logistics provider specializing in pharmaceutical, medical and biotechnology warehousing, distribution and order management and is the exclusive distributor of immunizing agents for Québec's public health system.